|
|

Peripapillary CNVM No Treatmentvu 77 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
|
|

Peripapillary CNVM No Treatmentvu 74 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
|
|

Peripapillary CNVM No Treatmentvu 59 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
|
|

Peripapillary CNVM No Treatmentvu 90 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
|
|

Peripapillary CNVM No Treatmentvu 65 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
|
|

Peripapillary CNVM No Treatmentvu 75 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
|
|

Peripapillary CNVM No Treatmentvu 70 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
|
|

Peripapillary CNVM No Treatmentvu 66 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
|
|

Peripapillary CNVM No Treatmentvu 64 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
|
|

Peripapillary CNVM No Treatmentvu 65 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
|
|

Peripapillary CNVM No Treatmentvu 66 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
|
|

Peripapillary CNVM No Treatmentvu 83 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
|
|

Peripapillary CNVM No Treatmentvu 46 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
|
|

Peripapillary CNVM No Treatmentvu 70 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
|
|

Peripapillary CNVM No Treatmentvu 66 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
|
|

Peripapillary CNVM No Treatmentvu 69 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
|
|

Recurrent toxoplasmosis with elevated IOPvu 77 fois48 year old man with 4 episodes over 40 years of vision loss from toxoplasmosis. His IOP was 44 on presentation.18 Février 2026
|
|

Recurrent toxoplasmosis with elevated IOPvu 79 fois48 year old man with 4 episodes over 40 years of vision loss from toxoplasmosis. His IOP was 44 on presentation.18 Février 2026
|
|

Recurrent toxoplasmosis with elevated IOPvu 70 fois48 year old man with 4 episodes over 40 years of vision loss from toxoplasmosis. His IOP was 44 on presentation.18 Février 2026
|
|

Recurrent toxoplasmosis with elevated IOPvu 52 fois48 year old man with 4 episodes over 40 years of vision loss from toxoplasmosis. His IOP was 44 on presentation.18 Février 2026
|
|

Recurrent toxoplasmosis with elevated IOPvu 58 fois48 year old man with 4 episodes over 40 years of vision loss from toxoplasmosis. His IOP was 44 on presentation.18 Février 2026
|
|

Recurrent toxoplasmosis with elevated IOPvu 68 fois48 year old man with 4 episodes over 40 years of vision loss from toxoplasmosis. His IOP was 44 on presentation.18 Février 2026
|
|

Recurrent toxoplasmosis with elevated IOPvu 76 fois48 year old man with 4 episodes over 40 years of vision loss from toxoplasmosis. His IOP was 44 on presentation.18 Février 2026
|
|

27 year old with migraine - normal imagingvu 92 fois18 Février 2026
|
|

27 year old with migraine - normal imagingvu 76 fois18 Février 2026
|
|

27 year old with migraine - normal imagingvu 91 fois18 Février 2026
|
|

27 year old with migraine - normal imagingvu 115 fois18 Février 2026
|
|

27 year old with migraine - normal imagingvu 117 fois18 Février 2026
|
|

27 year old with migraine - normal imagingvu 73 fois18 Février 2026
|
|

27 year old with migraine - normal imagingvu 83 fois18 Février 2026
|
|

27 year old with migraine - normal imagingvu 101 fois18 Février 2026
|
|

27 year old with migraine - normal imagingvu 71 fois18 Février 2026
|
|

27 year old with migraine - normal imagingvu 79 fois18 Février 2026
|
|

27 year old with migraine - normal imagingvu 70 fois18 Février 2026
|
|

27 year old with migraine - normal imagingvu 90 fois18 Février 2026
|
|

27 year old with migraine - normal imagingvu 75 fois18 Février 2026
|
|

27 year old with migraine - normal imagingvu 72 fois18 Février 2026
|
|

27 year old with migraine - normal imagingvu 85 fois18 Février 2026
|
|

27 year old with migraine - normal imagingvu 75 fois18 Février 2026
|
|

27 year old with migraine - normal imagingvu 83 fois18 Février 2026
|
|

27 year old with migraine - normal imagingvu 91 fois18 Février 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 240 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 264 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 258 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 170 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 136 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 157 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 164 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 130 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 125 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 171 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 150 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 130 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 101 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 146 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 155 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 129 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 133 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 115 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 123 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 155 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 145 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 145 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 130 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

NPDR and Severe macular ischemia sudden vision lossvu 118 fois60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OU11 Janvier 2026
|
|

Post Anti-VEGF RPE Tear (Vabysmo)vu 68 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
|
|

Post Anti-VEGF RPE Tear (Vabysmo)vu 76 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
|
|

Post Anti-VEGF RPE Tear (Vabysmo)vu 83 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
|
|

Post Anti-VEGF RPE Tear (Vabysmo)vu 96 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
|
|

Post Anti-VEGF RPE Tear (Vabysmo)vu 95 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
|
|

Post Anti-VEGF RPE Tear (Vabysmo)vu 92 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
|
|

Post Anti-VEGF RPE Tear (Vabysmo)vu 95 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
|
|

Post Anti-VEGF RPE Tear (Vabysmo)vu 79 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
|
|

Post Anti-VEGF RPE Tear (Vabysmo)vu 78 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
|
|

Post Anti-VEGF RPE Tear (Vabysmo)vu 73 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
|
|

Post Anti-VEGF RPE Tear (Vabysmo)vu 99 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
|
|

Post Anti-VEGF RPE Tear (Vabysmo)vu 82 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
|
|

Post Anti-VEGF RPE Tear (Vabysmo)vu 87 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
|
|

Post Anti-VEGF RPE Tear (Vabysmo)vu 64 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
|
|

Post Anti-VEGF RPE Tear (Vabysmo)vu 100 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
|
|

Post Anti-VEGF RPE Tear (Vabysmo)vu 88 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
|
|

Post Anti-VEGF RPE Tear (Vabysmo)vu 71 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
|
|

Post Anti-VEGF RPE Tear (Vabysmo)vu 83 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
|
|

CRB1 Dystrophy - Inherited Retinal Disease - 14 year old malevu 124 foisVision loss for 4 years OD 20/63, OS 20/16011 Janvier 2026
|
|

CRB1 Dystrophy - Inherited Retinal Disease - 14 year old malevu 144 foisVision loss for 4 years OD 20/63, OS 20/16011 Janvier 2026
|
|

CRB1 Dystrophy - Inherited Retinal Disease - 14 year old malevu 101 foisVision loss for 4 years OD 20/63, OS 20/16011 Janvier 2026
|
|

CRB1 Dystrophy - Inherited Retinal Disease - 14 year old malevu 115 foisVision loss for 4 years OD 20/63, OS 20/16011 Janvier 2026
|
|

CRB1 Dystrophy - Inherited Retinal Disease - 14 year old malevu 102 foisVision loss for 4 years OD 20/63, OS 20/16011 Janvier 2026
|
|

CRB1 Dystrophy - Inherited Retinal Disease - 14 year old malevu 147 foisVision loss for 4 years OD 20/63, OS 20/16011 Janvier 2026
|
|

CRB1 Dystrophy - Inherited Retinal Disease - 14 year old malevu 130 foisVision loss for 4 years OD 20/63, OS 20/16011 Janvier 2026
|
|

Bullous Retinoschisis - Asymptomaticvu 105 fois17 Décembre 2025
|
|

Bullous Retinoschisis - Asymptomaticvu 134 fois17 Décembre 2025
|
|

Bullous Retinoschisis - Asymptomaticvu 105 fois17 Décembre 2025
|
|

Hemi-CRVO - dual trunk veinvu 94 fois81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomy17 Décembre 2025
|
|

Hemi-CRVO - dual trunk veinvu 126 fois81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomy17 Décembre 2025
|
|

Hemi-CRVO - dual trunk veinvu 106 fois81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomy17 Décembre 2025
|
|

Hemi-CRVO - dual trunk veinvu 103 fois81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomy17 Décembre 2025
|
|

Hemi-CRVO - dual trunk veinvu 96 fois81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomy17 Décembre 2025
|
|

Hemi-CRVO - dual trunk veinvu 101 fois81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomy17 Décembre 2025
|
|

Hemi-CRVO - dual trunk veinvu 117 fois81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomy17 Décembre 2025
|
|
| 17965 photos sur 180 page(s) |
 |
3 |  |
 |
 |
 |
 |
 |
 |
 |
|